CLINICAL_TRIALS
trial_result
· 2023-06-28
Clinical Trial Update: Multiple Doses of AT-1501-A201 in Adults With ALS [Phase 2]
Summary
Phase 2 trial in adults with amyotrophic lateral sclerosis (ALS) evaluating multiple doses of AT-1501-A201 has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anelixis Therapeutics, LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-06-28